Bo Ahrén

91 – 100 of 398

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/af6f8d38-a95b-47b6-9ec5-5f69aa8d0e59?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
9
10
11
12
…
40
next »

2014
Mark Fibroblast Growth Factor 21 (FGF21) and Glucagon Like-Peptide 1 Contribute to Diabetes Resistance in Glucagon Receptor Deficient Mice.
Omar, Bilal ^LU ; Andersen, Birgitte ; Hald, Jacob ; Raun, Kirsten ; Nishimura, Erica and Ahrén, Bo ^LU (2014) In Diabetes 63(1). p.101-110
- Contribution to journal › Article
Mark Efficacy of vildagliptin versus sulfonylureas as add-on therapy to metformin: comparison of results from randomised controlled and observational studies.
Ahrén, Bo ^LU ; Mathieu, Chantal ; Bader, Giovanni ; Schweizer, Anja and Foley, James E (2014) In Diabetologia 57(7). p.1304-1307
- Contribution to journal › Article
Mark GLP-1 released to the mesenteric lymph duct in mice: Effects of glucose and fat.
Ohlsson, Lena ^LU ; Kohan, Alison B ; Tso, Patrick and Ahrén, Bo ^LU (2014) In Regulatory Peptides 189(Feb 28). p.40-45
- Contribution to journal › Article
Mark Equal improvement in glycaemia with lixisenatide given before breakfast or the main meal of the day.
Ahrén, Bo ^LU ; Vorokhobina, Natalia ; Souhami, Elisabeth ; Demil, Nacima ; Ye, Jenny and Aronson, Ronnie (2014) In Journal of Diabetes and its Complications 28(5). p.735-741
- Contribution to journal › Article
Mark Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes.
Farngren, Johan ^LU ; Persson, Margaretha ^LU ; Schweizer, A ; Foley, J E and Ahrén, Bo ^LU (2014) In Diabetes, Obesity and Metabolism 16(9). p.812-818
- Contribution to journal › Article
Mark Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes.
Omar, Bilal ^LU ; Liehua, Liu ; Yamada, Yuchiro ; Seino, Yutaka ; Marchetti, Piero and Ahrén, Bo ^LU (2014) In Diabetologia 57(9). p.1876-1883
- Contribution to journal › Article
Mark The mind and the belly: a glance at how the nervous system directs metabolism
Accili, D. ; Ahrén, Bo ^LU ; Boitard, C. ; Seino, S. ; Thorens, B. and Cerasi, E. (2014) In Diabetes, Obesity and Metabolism 16. p.1-3
- Contribution to journal › Debate/Note/Editorial
Mark Advancing Basal Insulin Replacement in Type 2 Diabetes Inadequately Controlled With Insulin Glargine Plus Oral Agents: A Comparison of Adding Albiglutide, a Weekly GLP-1 Receptor Agonist, Versus Thrice-Daily Prandial Insulin Lispro.
Rosenstock, Julio ; Fonseca, Vivian A ; Gross, Jorge L ; Ratner, Robert E ; Ahrén, Bo ^LU ; Chow, Francis C C ; Yang, Fred ; Miller, Diane ; Johnson, Susan L and Stewart, Murray W , et al. (2014) In Diabetes Care 37(8). p.2317-2325
- Contribution to journal › Article
Mark Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial
Jakubowicz, Daniela ; Froy, Oren ; Ahrén, Bo ^LU ; Boaz, Mona ; Landau, Zohar ; Bar-Dayan, Yosefa ; Ganz, Tali ; Barnea, Maayan and Wainstein, Julio (2014) In Diabetologia 57(9). p.1807-1811
- Contribution to journal › Article
Mark Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis
Otten, Julia ; Ahrén, Bo ^LU and Olsson, Tommy (2014) In Diabetologia 57(9). p.1781-1788
- Contribution to journal › Article

« previous
1
…
9
10
11
12
…
40
next »